// App-Quantinova.ai

: Molecular and Clinical Aspects of Aα Dysfibrinogenemia in 25 Patients from the Czech Republic

Researchers

Presenter

  • Eliska Ceznerova

Principal Investigators

  • Jana Stikarova

  • Pavla Roselova

  • Jirina Kaufmanova

  • Jiri Suttnar

  • Jan Louzil

  • Roman Kotlin

  • Peter Salaj

  • Jan E. Dyr

Medical Centers

  • Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Czech Republic

  • Center for thrombosis and hemostasis, Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Obstetrics/Gynecology

Disease

  • Postpartum hemorrhage

  • Venous thrombosis

Biomarkers

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved